{"id":607,"date":"2025-04-18T14:11:22","date_gmt":"2025-04-18T14:11:22","guid":{"rendered":"http:\/\/www.shotlow.com\/?p=607"},"modified":"2025-04-30T10:29:12","modified_gmt":"2025-04-30T10:29:12","slug":"concept-life-sciences-expands-expertise-with-key-appointments-to-scientific-advisory-board-and-investments-to-strengthen-integrated-drug-discovery-capabilities","status":"publish","type":"post","link":"http:\/\/www.shotlow.com\/index.php\/2025\/04\/18\/concept-life-sciences-expands-expertise-with-key-appointments-to-scientific-advisory-board-and-investments-to-strengthen-integrated-drug-discovery-capabilities\/","title":{"rendered":"Concept Life Sciences expands expertise with key appointments to Scientific Advisory Board and investments to strengthen integrated drug discovery capabilities"},"content":{"rendered":"<p><a href=\"https:\/\/highgrowth.scot\/concept-life-sciences-expands-expertise-with-key-appointments-to-scientific-advisory-board-and-investments-to-strengthen-integrated-drug-discovery-capabilities\/\" title=\"Concept Life Sciences expands expertise with key appointments to Scientific Advisory Board and investments to strengthen integrated drug discovery capabilities\" rel=\"nofollow\"><img loading=\"lazy\" width=\"768\" height=\"524\" src=\"http:\/\/www.shotlow.com\/wp-content\/uploads\/2025\/04\/hgs2-768x524-1.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" style=\"margin: auto;margin-bottom: 24px;max-width: 100%\" \/><\/a><\/p>\n<p><a href=\"https:\/\/74n5c4m7.r.eu-west-1.awstrack.me\/L0\/https:%2F%2Fwww.conceptlifesciences.com%2F\/1\/01020196388205fb-1268aaf7-dbb4-4550-b8d2-25a41db552d6-000000\/Nksds4CtAuV-UtPnuQSf-EUuf1c=421\" target=\"_blank\" rel=\"noreferrer noopener\">Concept Life Sciences (CLS)<\/a>, a leading integrated drug discovery, development, and manufacturing organisation backed by Limerston Capital, today announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors.<\/p>\n<p>CLS is pleased to welcome Professor Luke O\u2019Neill, and Dr. Shane Liddelow to its Scientific Advisory Board (SAB), while Dr. Ian Waddell, who joined the Board of Directors last year, continues to provide invaluable leadership.<\/p>\n<p>The appointments to the SAB reinforce CLS\u2019s position as a leading partner for innovative drug discovery solutions. Professor O\u2019Neill and Dr. Liddelow bring a wealth of expertise across immunology and neuroscience, respectively, enhancing CLS\u2019s ability to meet the evolving needs of the global life sciences industry.<\/p>\n<p>CLS has made major advancements in automated solid-phase peptide synthesis (SPPS) capabilities. Combined with in-house peptide experts, this enables it to accelerate client projects requiring challenging custom peptide synthesis.<\/p>\n<p>In addition, CLS has made a significant investment, amounting to a five-figure sum in GBP, to enhance its capabilities in Automated ADME (Absorption, Distribution, Metabolism, Excretion) systems and the purchase of a Supercritical Fluid Chromatography purification instrument. This strategic investment drives industry-leading assay turnaround times with no minimum volume requirement and strengthens CLS\u2019s ability to provide high-quality, tailored services, particularly for complex drug discovery projects.<\/p>\n<p>These investments further solidify CLS\u2019s standing as a key partner to pharmaceutical and biotech companies, providing comprehensive drug discovery services from early-stage research through to clinical trials.<\/p>\n<p>The news follows CLS\u2019s acquisition of Charnwood Discovery which completed at the end of 2024 and further enhances the company\u2019s integrated drug discovery offer. This underlines the business\u2019s growth strategy, demonstrating its ambitions and further strengthening its ability to accelerate drug candidates to clinic with high success rates and across different modalities.<\/p>\n<p><strong>About the Scientific Advisory Board Members:<\/strong><\/p>\n<ul class=\"wp-block-list\">\n<li>Professor Luke O\u2019Neill, FRS, is an immunologist and Chair of Biochemistry at Trinity College Dublin. With over 460 peer-reviewed publications, his research focuses on inflammation, innate immunity, and immunometabolism, providing deep expertise in areas critical to drug discovery. Professor O\u2019Neill has received over 110,000 citations and has an h-index of 160, underscoring his significant contributions to the field.<\/li>\n<\/ul>\n<ul class=\"wp-block-list\">\n<li>Dr. Shane Liddelow is an Associate Professor at NYU Langone Medical Center, specialising in neurodegenerative diseases. His research into the role of astrocytes in diseases like Alzheimer\u2019s and Parkinson\u2019s offers valuable insight for neurodegenerative drug discovery. Dr. Liddelow has garnered over 30,000 citations and holds an h-index of 52, which reflects his important research in neurodegeneration.<\/li>\n<\/ul>\n<ul class=\"wp-block-list\">\n<li>Dr. Ian Waddell, appointed to the CLS Board of Directors last year, has more than 27 years of experience across all stages of drug discovery. His expertise spans cardiovascular and oncology disease areas, and his leadership in the field has been instrumental in advancing drug development programs.<\/li>\n<\/ul>\n<p>Ben Cliff, CEO of Concept Life Sciences, commented: \u201c<em>The addition of Luke, Shane, and Ian to our advisory and leadership teams is an exciting step in enhancing our scientific expertise and global service offering.<\/em><\/p>\n<p><em>\u201cAs we strive to stay at the forefront of research and innovation, our continued investments in technology and talent, including our protein production capabilities and cutting-edge purification systems, reinforce our commitment to delivering high-quality, integrated services to the global biopharmaceutical community<\/em>.\u201d<\/p>\n<p>Dr. Ian Waddell, added: &#8220;<em>My role with the Scientific Advisory Board allows me to contribute from a strategic leadership perspective, ensuring that our scientific initiatives align with the company&#8217;s broader goals. The expertise of Professor O&#8217;Neill and Dr. Liddelow, combined with continued investments in cutting-edge technologies, reinforces CLS\u2019s commitment to advancing drug discovery and I look forward to collaborating with such a distinguished panel to drive impactful outcomes for clients and the wider industry<\/em>.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Concept Life Sciences (CLS), a leading integrated drug discovery, development, and manufacturing organisation backed by Limerston Capital, today announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors. CLS is pleased to welcome Professor Luke O\u2019Neill, and Dr. Shane Liddelow to its Scientific Advisory Board (SAB), while [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":609,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"_links":{"self":[{"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/posts\/607"}],"collection":[{"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/comments?post=607"}],"version-history":[{"count":2,"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/posts\/607\/revisions"}],"predecessor-version":[{"id":610,"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/posts\/607\/revisions\/610"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/media\/609"}],"wp:attachment":[{"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/media?parent=607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/categories?post=607"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.shotlow.com\/index.php\/wp-json\/wp\/v2\/tags?post=607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}